You can order this product on prescription after adding it in your basket on checkout .

Hover

Rejuran s (1×1 ml)

In Stock

£69.00( excl. VAT )

Let’s talk on WhatsApp

Rejuran S (1 × 1ml) is an advanced polynucleotide injectable designed for professional aesthetic practitioners seeking regenerative skin treatment solutions.

Based on PN technology, Rejuran S is used in medical aesthetics as a skin booster aimed at supporting skin quality improvement rather than providing traditional filler-based volume correction.

Its formulation makes it part of the growing category of polynucleotide treatments used by aesthetic clinics worldwide. Practitioners looking to buy Rejuran S (1×1 ml) online can access this professional injectable solution for clinic-based applications.

Rejuran S should only be administered by qualified healthcare professionals following appropriate patient assessment and manufacturer guidance.

Description

Clinical Description

Rejuran S (1 × 1ml) is a professional injectable polynucleotide (PN) skin rejuvenation device designed for use in aesthetic medicine procedures. It belongs to the category of regenerative skin boosters, using purified polynucleotide technology derived from salmon DNA fragments to support improvements in skin quality and tissue condition.

Unlike traditional hyaluronic acid dermal fillers that primarily provide structural volume, Rejuran S works through a bioregenerative approach, where polynucleotide molecules are designed to support the skin’s natural repair environment and improve dermal characteristics.

Rejuran S is specifically formulated for areas requiring targeted skin improvement, including areas where practitioners seek enhanced skin texture, elasticity, and overall skin condition. The product contains polynucleotide (PN) as its key active component. The exact concentration, excipients, and complete formulation details should be confirmed through the official manufacturer documentation.

What Rejuran S Is Similar To

Rejuran S belongs to the polynucleotide skin booster category and can be compared with other regenerative injectable treatments such as Rejuran I and other PN-based products used in aesthetic medicine.

Rejuran S and Rejuran I share the same polynucleotide-based technology but are designed for different treatment focuses. Rejuran S is generally positioned for areas requiring more targeted skin improvement, while Rejuran I is commonly associated with delicate skin areas such as the periocular region.

Another comparable category is hyaluronic acid-based skin boosters such as Profhilo. While both approaches aim to improve skin quality, their mechanisms differ. Profhilo uses stabilised hyaluronic acid technology, whereas Rejuran S uses polynucleotide technology designed to support the skin regeneration environment.

These products have different compositions, indications, and clinical protocols.

Treatment Areas / Indications

Based on available product information, Rejuran S is intended for professional aesthetic applications involving targeted skin rejuvenation.

Reported treatment applications include:

Areas requiring improvement in skin texture and quality
Localised areas requiring regenerative skin support
Facial skin rejuvenation procedures

The product is commonly associated with targeted treatment areas where thicker skin or specific skin concerns require a specialised PN formulation.

Specific approved indications and anatomical treatment areas should always be confirmed through the official manufacturer Instructions for Use (IFU).

Usage / Administration (IFU-Only Section)

Rejuran S should only be administered by qualified medical professionals trained in injectable aesthetic procedures.

Administration must follow the official manufacturer Instructions for Use.

Available information:

Treatment should be performed under appropriate aseptic conditions and according to professional medical-device standards.

Some practitioners describe specific injection patterns and treatment protocols for polynucleotide products; however, these methods are not considered official manufacturer guidance unless specifically stated within the Rejuran S IFU.

Ingredient List

Rejuran S contains polynucleotide (PN) as its primary active component.

Available formulation information:

Polynucleotide (PN) – purified DNA-derived biopolymer used as the key active ingredient in the formulation.

The exact composition should be verified from the official product packaging and manufacturer documentation supplied with the device.

Presentation & Longevity

Presentation

Rejuran S is supplied as:

1 × 1ml prefilled syringe

The product presentation is designed for professional aesthetic use and should be stored and handled according to manufacturer requirements.

Longevity

As a polynucleotide-based injectable, Rejuran S is designed to support gradual improvement in skin quality through biological mechanisms rather than providing immediate volume augmentation like traditional dermal fillers.

The duration of visible effects can vary depending on:

individual patient characteristics,
treatment area,
practitioner protocol,
biological response.

A specific manufacturer-confirmed longevity period for Rejuran S was not identified in publicly available product documentation.

Safety Notes / Contraindications

Rejuran S (1 × 1ml) is an injectable polynucleotide medical aesthetic device intended for professional use by qualified healthcare practitioners with appropriate training in aesthetic injection procedures.

Before treatment, practitioners should complete a suitable patient assessment and review medical history, allergies, previous aesthetic treatments, and potential contraindications according to the manufacturer’s Instructions for Use.

Important safety considerations include:

Use is contraindicated in patients with known hypersensitivity to any component of the product.
Treatment should not be performed in areas affected by active skin infections, inflammation, or compromised skin conditions.
Patients with a history of severe allergic reactions or sensitivity to product components should be assessed carefully before treatment.
The product should only be used according to the approved indications and manufacturer instructions.

As with other injectable aesthetic treatments, temporary local reactions may occur, including redness, swelling, tenderness, bruising, itching, or discomfort at the injection site.

Patients should be informed that individual responses vary and outcomes depend on factors including skin condition, treatment area, practitioner technique, and biological response.

Regulatory Status

Rejuran S is marketed as a professional injectable polynucleotide-based aesthetic device.

Available product documentation identifies:

Product category: Polynucleotide (PN) injectable skin booster / regenerative aesthetic device
Presentation: 1 × 1ml syringe
Intended users: Qualified medical aesthetic professionals

Rejuran products are manufactured by PharmaResearch Co., Ltd., a South Korean biotechnology and pharmaceutical company specialising in regenerative medicine technologies.

Regulatory classification and market authorisation depend on the intended country of sale. Practitioners should verify the current product packaging, manufacturer documentation, and applicable regulatory requirements before use.

Regulatory classification not fully specified in publicly available documentation; verify on the product pack or manufacturer’s IFU.

FAQ

1. What is Rejuran S (1 × 1ml) and how does it work?

Rejuran S is a polynucleotide-based injectable used in professional aesthetic medicine. Its active component is purified polynucleotide (PN), a biological material derived from DNA fragments. PN technology is designed to support the skin’s regenerative environment by providing a favourable matrix for tissue repair processes.

Unlike traditional hyaluronic acid fillers, Rejuran S is not primarily designed for volumising or reshaping facial contours. Instead, it belongs to the category of regenerative skin boosters focused on improving overall skin condition and quality.

2. What is the difference between Rejuran S and other Rejuran products?

The Rejuran range includes different formulations designed for different aesthetic applications. Rejuran S is generally positioned as a formulation for targeted skin improvement, while other products in the range may be developed for specific anatomical areas or treatment objectives.

The main difference between Rejuran formulations relates to product characteristics, intended application areas, and clinical use. Practitioners should refer to each product’s official documentation when selecting a suitable formulation.

Product selection should always follow manufacturer guidance and professional clinical assessment.

3. How does Rejuran S compare with hyaluronic acid skin boosters such as Profhilo®?

Rejuran S and hyaluronic acid skin boosters such as Profhilo® belong to different injectable categories.

Rejuran S uses polynucleotide technology, while Profhilo® uses stabilised hyaluronic acid. Both are used within aesthetic medicine for improving skin quality, but their compositions and biological mechanisms differ.

Hyaluronic acid-based products primarily rely on HA’s hydration and tissue interaction properties, whereas PN products are designed around polynucleotide-based regenerative mechanisms.

These products should not be considered interchangeable, and practitioners should select treatments according to patient assessment and product indications.

4. How long do results from Rejuran S last?

The duration of visible effects following Rejuran S treatment varies between individuals and depends on several factors, including skin condition, treatment area, practitioner protocol, and biological response.

Polynucleotide-based treatments are designed to produce gradual skin-quality changes rather than immediate volumising effects. The timeline and duration of results should be discussed according to available manufacturer information and clinical evaluation.

A specific manufacturer-confirmed longevity period for Rejuran S was not identified in publicly available documentation.

5. Who can administer Rejuran S?

Rejuran S should only be administered by appropriately qualified healthcare professionals who have suitable training and experience in injectable aesthetic procedures.

The practitioner is responsible for:

assessing patient suitability,
reviewing contraindications,
following the manufacturer’s IFU,
maintaining appropriate infection-control procedures.

Patients considering Rejuran S treatment should consult a qualified medical professional who can evaluate whether the product is suitable for their individual circumstances.

0/5 (0 Reviews)